封面
市场调查报告书
商品编码
1631198

心臟衰竭POC 和 LOC 设备市场分析报告:按类型、技术、最终用途、地区和细分市场预测,2025-2030 年

Heart Failure POC And LOC Devices Market Analysis Report By Type (Proteomic Testing, Metabolomic Testing), By Technology (Microfluidics), By End-use ( Clinics, Home), By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

心臟衰竭POC 和 LOC 设备市场的成长和趋势

根据 Grand View Research, Inc. 的最新报告,全球心臟衰竭POC 和 LOC 设备市场规模预计到 2030 年将达到 2.5102 亿美元,2025 年至 2030 年的复合年增长率为 15.09%。在诊断领域,市场受到疾病从晚期检测到早期检测的模式转移的推动,这是抑制医疗成本上升的可行策略。这种转变导致了一次性、低成本 LOC 设备的开发,该设备将各种感测器和相关配件整合在一个空间中,以从单一检体中检测心臟生物标记来评估心臟病的风险。

此外,开发基于预测模型技术的决策支援软体来分析 LOC 检测测量的资料以实现治疗监测是市场驱动因素之一。此外,正在进行的基于唾液的奈米生物晶片测试在测量心肌梗塞方面的应用研究正在推动有机收益的成长。

POC 测试可在各种环境中节省成本,包括医院、综合诊所和偏远地区。在美国,POC 设备的采用使胸痛科的入院人数减少了 20%,从而大大节省了时间和成本。

在心臟监测部门(美国),引入 POC 肌钙蛋白检测缩短了住院时间,降低了住院率,并且无需进行昂贵的多次检查,从而使每位患者的费用降低了 25%。此外,将智慧型手机和应用程式整合到 POC 诊断中以管理个人的心臟健康是心臟衰竭POC 和 LOC 设备市场的关键技术创新之一。

心臟衰竭POC 和 LOC 设备市场报告重点

  • 蛋白质体学分析包括检测肌钙蛋白、肌红蛋白和肌酸激酶 MB同功异构酵素(CK-MB) 等蛋白质标记的产品。
  • 由于目前大多数可用产品都是基于蛋白质标记物的测试,因此该部分占据了主要的收益占有率。
  • 越来越多地采用微流体LOC 技术来评估假定的生物标记物,导致该技术的收益占有率最大。
  • 微流体技术已实现多种生物应用,包括杂合反应技术、酵素测定和 PCR。
  • 诊所,包括医生办公室、药房/零售诊所、紧急护理诊所和非诊所,是主要的收益终端用户。
  • 全科医生大量采用 POC 设备进行快速检查、儘早做出治疗决定、及时就诊并减少患者的不确定性,从而推动诊所的收益成长。
  • 由于大量基层医疗诊所采用 POC 心臟标记检测作为心臟衰竭早期检测的手段,美国在全球心臟衰竭POC 和 LOC 设备市场占据主导地位。
  • 都市化加快和人口老化加剧了亚洲国家对强劲和改进的医疗保健服务的需求,例如用于常规心臟健康监测的即时诊断。
  • 此外,我们正在努力对初级医务负责人进行 POC 心臟肌钙蛋白 T/心臟肌钙蛋白 I 生物标记的培训。因此,预计亚洲国家的 POC 设备采用率将会飙升。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章市场变数、趋势与范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场趋势与展望
  • 市场动态
  • 市场限制因素分析
  • 商业环境分析
    • 依因素(政治/法律、经济/技术)进行 SWOT 分析
    • 波特五力分析

第四章 类型业务分析

  • 心臟衰竭POC 和 LOC 设备市场:类型变化分析
  • 蛋白质体学检测
    • 蛋白质体学检测市场,2018 - 2030
  • 代谢体学测试
    • 代谢体学测试市场,2018 - 2030
  • 基因组检测
    • 基因组检测市场,2018 - 2030

第五章 技术业务分析

  • 心臟衰竭POC 和 LOC 设备市场:技术变革分析
  • 微流体
    • 微流体市场,2018 - 2030
  • 基于阵列的系统
    • 基于阵列的系统市场,2018 - 2030
  • 其他的
    • 其他市场,2018-2030

第六章 最终用途业务分析

  • 心臟衰竭POC 和 LOC 设备市场:最终用途变化分析
  • 医院
    • 医院市场,2018-2030
  • 实验室
    • 实验室市场,2018-2030
  • 诊所
    • 诊所市场,2018-2030
  • 住宅
    • 住宅市场,2018-2030
  • 辅助生活医疗设施
    • 辅助生活医疗设施市场,2018-2030 年

第七章 区域经营分析

  • 2024 年及 2030 年心臟衰竭POC 和 LOC 设备市场占有率(按地区)
  • 北美洲
    • 2018 年至 2030 年北美心臟衰竭POC 和 LOC 设备市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018 年至 2030 年欧洲心臟衰竭POC 和 LOC 设备市场
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2018 年至 2030 年亚太地区心臟衰竭POC 和 LOC 设备市场
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 2018 年至 2030 年拉丁美洲心臟衰竭POC 和 LOC 设备市场
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2018 年至 2030 年中东和非洲心臟衰竭POC 和 LOC 设备市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 公司分类
  • 战略地图
  • 2024 年公司市场占有率分析
  • 公司简介/上市公司
    • Abbott
    • Danahar
    • Siemens Healthineers
    • F. Hoffmann-La Roche Ltd.
    • Quidel Corporation
    • bioMerieux SA
    • Trinity BIoTech
    • Abaxis, Inc
Product Code: GVR-3-68038-980-7

Heart Failure POC And LOC Devices Market Growth & Trends:

The global heart failure POC and LOC devices market size is expected to reach USD 251.02 million by 2030 and is projected to grow at a CAGR of 15.09% from 2025 to 2030, according to a new report by Grand View Research, Inc. A paradigm shift in diagnostic sectors from late-stage disease detection to early identification of diseases as a viable strategy to curb rising healthcare costs has driven the market. This shift has led to the development of disposable and low-cost LOC devices that integrate various sensors and associated accessories in a single space for detection of the cardiac biomarkers from a single specimen to evaluate the risk of having a heart attack.

Furthermore, the development of predictive modeling techniques-based decision support software to analyze the data measured by the LOC assays to enable therapy monitoring is one of the key market drivers. Also, ongoing studies on the application of saliva-based nano-biochip tests for measuring myocardial infarction is driving organic revenue growth.

POC testing exhibits potential savings across various settings, including hospitals, general practice, and remote areas. In the U.S., the employment of POC devices resulted in a 20% decrease in hospital admissions to the chest pain unit, resulting in substantial savings in time and costs.

In the cardiac observation unit (U.S.), the implementation of POC troponin testing helped reduce hospital stays, decrease admission rates, and remove the need for multiple costly procedures, resulting in 25% cost saving per patient. Furthermore, the integration of smartphones and apps in POC diagnostics for managing the cardiac health of an individual is one of the significant innovations in Heart Failure POC & LOC Devices market.

Heart Failure POC And LOC Devices Market Report Highlights:

  • Proteomic analysis includes products that test protein markers, such as troponin, myoglobin, and Creatine Kinase MB Isoenzyme (CK-MB)
  • This segment accounted for the leading revenue share, as most of the currently available products are based on testing of protein markers
  • Increasing implementation of microfluidic LOC technology for assessing putative biomarkers has led to the largest revenue share of this technology
  • Microfluidic technology has been implemented for various biological applications, such as immunohybridization techniques, enzymatic assays, PCR, and others
  • Clinics that include physician's office, pharmacy & retail clinics, urgent care clinics, and non-practice clinics are the key revenue generating end-users
  • A high usage rate of POC devices by general practitioners for rapid investigation, deciding early treatment, timely referral, and less uncertainty for patients has driven the revenue growth through clinics
  • The U.S. dominated the global Heart Failure POC & LOC devices market owing to the presence of a substantial number of primary care clinics that are deploying POC cardiac marker test as a measure for early detection of heart failure
  • Expanding urbanization and increasing geriatric population underpin the demand for robust and improved healthcare services such as POC diagnostics for routine cardiac health monitoring in Asian countries
  • Moreover, initiatives are undertaken for training young healthcare personnel about POC cardiac troponin T/cardiac troponin I biomarkers. This, in turn, is anticipated to result in the surging adoption rate of POC devices in Asian countries

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
  • 3.5. Market Restraint Analysis
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis

Chapter 4. Type Business Analysis

  • 4.1. Heart Failure POC & LOC Devices Market: Type Movement Analysis
  • 4.2. Proteomic Testing
    • 4.2.1. Proteomic Testing Market, 2018 - 2030 (USD Million)
  • 4.3. Metabolomic Testing
    • 4.3.1. Metabolomic Testing Market, 2018 - 2030 (USD Million)
  • 4.4. Genomic Testing
    • 4.4.1. Genomic Testing Market, 2018 - 2030 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Heart Failure POC & LOC Devices Market: Technology Movement Analysis
  • 5.2. Microfluidics
    • 5.2.1. Microfluidics Market, 2018 - 2030 (USD Million)
  • 5.3. Array-based Systems
    • 5.3.1. Array-based Systems Market, 2018 - 2030 (USD Million)
  • 5.4. Others
    • 5.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. Heart Failure POC & LOC Devices Market: End-use Movement Analysis
  • 6.2. Hospitals
    • 6.2.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 6.3. Laboratories
    • 6.3.1. Laboratories Market, 2018 - 2030 (USD Million)
  • 6.4. Clinics
    • 6.4.1. Clinics Market, 2018 - 2030 (USD Million)
  • 6.5. Home
    • 6.5.1. Home Market, 2018 - 2030 (USD Million)
  • 6.6. Assisted Living Healthcare Facilities
    • 6.6.1. Assisted Living Healthcare Facilities Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Heart Failure POC & LOC Devices Market Share By Region, 2024 & 2030
  • 7.2. North America
    • 7.2.1. North America Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Target Disease Prevalence
      • 7.2.2.3. Competitive Scenario
      • 7.2.2.4. Regulatory Framework
      • 7.2.2.5. Reimbursement Scenario
      • 7.2.2.6. U.S. Heart failure POC & LOC devices Market, 2018 - 2030 (USD MILLION)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Reimbursement Scenario
      • 7.2.3.6. Canada Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Target Disease Prevalence
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Regulatory Framework
      • 7.2.4.5. Reimbursement Scenario
      • 7.2.4.6. Mexico Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.3.2. Germany
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target Disease Prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. Regulatory Framework
      • 7.3.2.5. Reimbursement Scenario
      • 7.3.2.6. Germany Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Reimbursement Scenario
      • 7.3.3.6. UK Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Reimbursement Scenario
      • 7.3.4.6. France Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Reimbursement Scenario
      • 7.3.5.6. Italy Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Reimbursement Scenario
      • 7.3.6.6. Spain Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Reimbursement Scenario
      • 7.3.7.6. Denmark Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Reimbursement Scenario
      • 7.3.8.6. Sweden Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Reimbursement Scenario
      • 7.3.9.6. Norway Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Regulatory Framework
      • 7.4.2.5. Reimbursement Scenario
      • 7.4.2.6. Japan Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Reimbursement Scenario
      • 7.4.3.6. China Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. Reimbursement Scenario
      • 7.4.4.6. India Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Reimbursement Scenario
      • 7.4.5.6. South Korea Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Reimbursement Scenario
      • 7.4.6.6. Australia Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Reimbursement Scenario
      • 7.4.7.6. Thailand Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Regulatory Framework
      • 7.5.2.5. Reimbursement Scenario
      • 7.5.2.6. Brazil Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Reimbursement Scenario
      • 7.5.3.6. Argentina Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Regulatory Framework
      • 7.6.2.5. Reimbursement Scenario
      • 7.6.2.6. South Africa Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Reimbursement Scenario
      • 7.6.3.6. Saudi Arabia Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Reimbursement Scenario
      • 7.6.4.6. UAE Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Reimbursement Scenario
      • 7.6.5.6. Kuwait Heart failure POC & LOC devices Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Abbott
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.1.3. Collection Site Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Danahar
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.2.3. Collection Site Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Siemens Healthineers
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.3.3. Collection Site Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. F. Hoffmann-La Roche Ltd.
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.4.3. Collection Site Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Quidel Corporation
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.5.3. Collection Site Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. bioMerieux S.A
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.6.3. Collection Site Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Trinity Biotech
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.7.3. Collection Site Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Abaxis, Inc
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 8.4.8.3. Collection Site Benchmarking
      • 8.4.8.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 5 Global Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 6 Global Heart Failure POC & LOC Devices Market, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Heart Failure POC & LOC Devices Market, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 9 North America Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 10 North America Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 13 U.S. Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 14 Mexico Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 15 Mexico Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 16 Mexico Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 17 Canada Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Canada Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 19 Canada Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 20 Europe Heart Failure POC & LOC Devices Market, by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 22 Europe Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 23 Europe Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 24 Germany Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 25 Germany Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 26 Germany Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 27 UK Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 28 UK Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 29 UK Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 30 France Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 France Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 32 France Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 33 Italy Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 34 Italy Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 35 Italy Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 36 Spain Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 37 Spain Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 38 Spain Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 39 Denmark Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 40 Denmark Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 41 Denmark Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 42 Sweden Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 43 Sweden Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 44 Sweden Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 45 Norway Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 46 Norway Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 47 Norway Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Heart Failure POC & LOC Devices Market, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 52 China Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 53 China Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 54 China Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 55 Japan Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 56 Japan Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 57 Japan Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 58 India Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 59 India Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 60 India Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 61 South Korea Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 62 South Korea Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 63 South Korea Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 64 Australia Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 65 Australia Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 66 Australia Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 67 Thailand Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 68 Thailand Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 69 Thailand Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 70 Latin America Heart Failure POC & LOC Devices Market, by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 72 Latin America Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 73 Latin America Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 74 Brazil Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 75 Brazil Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 76 Brazil Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 79 Argentina Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Heart Failure POC & LOC Devices Market, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 86 South Africa Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 90 UAE Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 91 UAE Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 92 UAE Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Heart Failure POC & LOC Devices Market, by Type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Heart Failure POC & LOC Devices Market, by Technology, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Heart Failure POC & LOC Devices Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Heart Failure POC & LOC Devices Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Heart Failure POC & LOC Devices Market, Type Movement Analysis
  • Fig. 16 Global Heart Failure POC & LOC Devices Market, for Proteomic Testing, 2018 - 2030 (USD Million)
  • Fig. 17 Global Heart Failure POC & LOC Devices Market, for Metabolomic Testing, 2018 - 2030 (USD Million)
  • Fig. 18 Global Heart Failure POC & LOC Devices Market, for Genomic Testing, 2018 - 2030 (USD Million)
  • Fig. 19 Global Heart Failure POC & LOC Devices Market, Technology Movement Analysis
  • Fig. 20 Global Heart Failure POC & LOC Devices Market, for Microfluidics, 2018 - 2030 (USD Million)
  • Fig. 21 Global Heart Failure POC & LOC Devices Market, for Array-based Systems, 2018 - 2030 (USD Million)
  • Fig. 22 Global Heart Failure POC & LOC Devices Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 23 Global Heart Failure POC & LOC Devices Market, End-use Movement Analysis
  • Fig. 24 Global Heart Failure POC & LOC Devices Market, for Hospitals, 2018 - 2030 (USD Million)
  • Fig. 25 Global Heart Failure POC & LOC Devices Market, for Laboratories, 2018 - 2030 (USD Million)
  • Fig. 26 Global Heart Failure POC & LOC Devices Market, for Clinics, 2018 - 2030 (USD Million)
  • Fig. 27 Global Heart Failure POC & LOC Devices Market, for Home, 2018 - 2030 (USD Million)
  • Fig. 28 Global Heart Failure POC & LOC Devices Market, for Assisted Living Healthcare Facilities, 2018 - 2030 (USD Million)
  • Fig. 29 Regional Marketplace: Key Takeaways
  • Fig. 30 Regional Outlook, 2024 & 2030
  • Fig. 31 Global Heart Failure POC & LOC Devices Market, Region Movement Analysis
  • Fig. 32 North America Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 34 Canada Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 38 UK Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 39 France Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 41 Spain Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 44 Norway Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 46 Japan Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 47 China Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 48 India Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 49 Australia Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 58 UAE Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait Heart Failure POC & LOC Devices Market, 2018 - 2030 (USD Million)